Case Reports in Dementia

Case Reports in Dementia Photo The goal of much of the research activity in dementia is to develop interventions for 'treatment' or even 'cure'. The classical bench to bedside paradigm has been disappointing in dementia. There is a long list of putative dementia treatment compounds with favourable pre-clinical and early phase trial data that have been neutral or even potentially harmful when assessed in phase III studies. Lewy body dementia is a common but frequently under diagnosed cause of dementia often mistaken for the more familiar entity of Alzheimer disease. Clinically the distinction is important, because it can have profound implications for management. The diagnosis of Lewy body dementia has important implications. It is associated with a high incidence of neuroleptic sensitivity, necessitating great caution in the use of these common antipsychotic agents. Early studies indicate cholinesterase inhibitors can be beneficial for treating the hallucinations and behaviour disturbances that afflict these patients and might also improve cognition.
  • AIDS associated Dementia Case Report
  • Patients living in care
  • Epileptic seizures and Dementia
  • Hospice person with Cancer and Dementia

Are you interested in

Mail us at

Program Enquiry
dementia@neurologymeeting.com
Sponsorship/ Exhibitor
sponsoraac@alliedacademies.com
General Enquiry
dementia@neurologymeeting.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.